Published in Vaccine on November 08, 2007
Transient facial nerve paralysis (Bell's palsy) following intranasal delivery of a genetically detoxified mutant of Escherichia coli heat labile toxin. PLoS One (2009) 1.82
Cholera toxin B: one subunit with many pharmaceutical applications. Toxins (Basel) (2015) 0.83
Clinical characteristics and cerebrospinal fluid parameters in patients with peripheral facial palsy caused by Lyme neuroborreliosis compared with facial palsy of unknown origin (Bell's palsy). BMC Infect Dis (2011) 0.82
Safety of MF59-adjuvanted influenza vaccination in the elderly: results of a comparative study of MF59-adjuvanted vaccine versus nonadjuvanted influenza vaccine in northern Italy. Am J Epidemiol (2013) 0.75
Contralateral facial nerve palsy following mandibular second molar removal: is there co-relation or just coincidence? Pan Afr Med J (2014) 0.75
Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. N Engl J Med (2004) 4.10
Absence of a paternally inherited FOXP2 gene in developmental verbal dyspraxia. Am J Hum Genet (2006) 2.14
Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives. Pediatr Infect Dis J (2005) 2.06
Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope. AIDS (2008) 2.06
Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine (2010) 1.99
Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Pediatr Infect Dis J (2006) 1.94
Rationale for pertussis booster vaccination throughout life in Europe. Lancet Infect Dis (2011) 1.74
In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children. AIDS (2007) 1.70
Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine (2007) 1.66
Relation of chronic and acute glycemic control on mortality in acute myocardial infarction with diabetes mellitus. Am J Cardiol (2005) 1.64
Mercury exposure in children with autistic spectrum disorder: case-control study. J Child Neurol (2004) 1.57
An alphavirus replicon particle chimera derived from venezuelan equine encephalitis and sindbis viruses is a potent gene-based vaccine delivery vector. J Virol (2003) 1.56
Benefits of bilateral electrical stimulation with the nucleus cochlear implant in adults: 6-month postoperative results. Otol Neurotol (2004) 1.54
Reproductive health of adolescent girls perinatally infected with HIV. Am J Public Health (2007) 1.53
Effect of MRI on treatment results or decision making in patients with lumbosacral radiculopathy referred for epidural steroid injections: a multicenter, randomized controlled trial. Arch Intern Med (2011) 1.52
Functional magnetic resonance imaging activation of the brain in children: real acupoint versus sham acupoint. J Child Neurol (2010) 1.51
Effect of acupuncture on the brain in children with spastic cerebral palsy using functional neuroimaging (FMRI). J Child Neurol (2008) 1.51
Three-year surveillance of intussusception in children in Switzerland. Pediatrics (2007) 1.45
Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine (2007) 1.44
Influenza vaccination among healthcare workers in a university children's hospital. Infect Control Hosp Epidemiol (2005) 1.32
Birth defects among children born to human immunodeficiency virus-infected women: pediatric AIDS clinical trials protocols 219 and 219C. Pediatr Infect Dis J (2010) 1.31
Association of site-specific and participant-specific factors with retention of children in a long-term pediatric HIV cohort study. Am J Epidemiol (2008) 1.31
New pertussis vaccination strategies beyond infancy: recommendations by the global pertussis initiative. Clin Infect Dis (2004) 1.29
Pediatric stroke among Hong Kong Chinese subjects. Pediatrics (2004) 1.28
Prevalence of elevated cholesterol and associated risk factors among perinatally HIV-infected children (4-19 years old) in Pediatric AIDS Clinical Trials Group 219C. J Acquir Immune Defic Syndr (2005) 1.28
Clinical and safety impact of an inpatient pharmacist-directed anticoagulation service. J Hosp Med (2011) 1.24
Antibiotic therapy for pediatric community-acquired pneumonia: do we know when, what and for how long to treat? Pediatr Infect Dis J (2012) 1.19
Incidence of noninfectious conditions in perinatally HIV-infected children and adolescents in the HAART era. Arch Pediatr Adolesc Med (2009) 1.16
Prospective surveillance of hospitalisations associated with varicella-zoster virus infections in children and adolescents. Eur J Pediatr (2005) 1.14
Meta-analysis of association between a catechol-O-methyltransferase gene polymorphism and attention deficit hyperactivity disorder. Behav Genet (2006) 1.14
How do physicians immunize their own children? Differences among pediatricians and nonpediatricians. Pediatrics (2005) 1.13
A superior semicircular canal dehiscence syndrome multicenter study: is there an association between size and symptoms? Otol Neurotol (2010) 1.12
Pertussis Across the Globe: Recent Epidemiologic Trends From 2000 to 2013. Pediatr Infect Dis J (2015) 1.12
The Brighton Collaboration: addressing the need for standardized case definitions of adverse events following immunization (AEFI). Vaccine (2002) 1.11
Immunogenicity of a reduced schedule of meningococcal group C conjugate vaccine given concomitantly with the Prevenar and Pediacel vaccines in healthy infants in the United Kingdom. Clin Vaccine Immunol (2008) 1.10
Relationship between five common viruses and febrile seizure in children. Arch Dis Child (2007) 1.10
Meatoplasty for lateral stenosis of the external auditory canal. Laryngoscope (2002) 1.09
Association of hypercholesterolemia incidence with antiretroviral treatment, including protease inhibitors, among perinatally HIV-infected children. J Acquir Immune Defic Syndr (2008) 1.09
Standardised case definitions for adverse events following immunisation. Lancet (2013) 1.09
Addressing the needs and gaps in safety assessment of vaccines during clinical trials in resource limited countries. Vaccine (2011) 1.09
Clara cell secretory protein deficiency alters clara cell secretory apparatus and the protein composition of airway lining fluid. Am J Respir Cell Mol Biol (2002) 1.08
Two-stage genome-wide association study identifies variants in CAMSAP1L1 as susceptibility loci for epilepsy in Chinese. Hum Mol Genet (2011) 1.07
International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines. Vaccine (2013) 1.05
Intussusception: incidence and treatment-insights from the nationwide German surveillance. J Pediatr Gastroenterol Nutr (2011) 1.03
Examining warfarin underutilization rates in patients with atrial fibrillation: Detailed chart review essential to capture contraindications to warfarin therapy. Thromb J (2008) 1.03
How to pre-process Raman spectra for reliable and stable models? Anal Chim Acta (2011) 1.03
Measles eradication in the Americas: progress to date. J Infect Dis (2004) 1.02
Vaccination policies for health-care workers in acute health-care facilities in Europe. Vaccine (2011) 1.02
Topiramate-valproate-induced hyperammonemic encephalopathy syndrome: case report. J Child Neurol (2005) 1.01
Eleven years of Inflexal V-a virosomal adjuvanted influenza vaccine. Vaccine (2009) 1.01
Human prion diseases: epidemiology and integrated risk assessment. Lancet Neurol (2003) 1.01
Association between ABCB1 C3435T polymorphism and drug-resistant epilepsy in Han Chinese. Epilepsy Behav (2007) 1.01
Characterization of human immunodeficiency virus Gag-specific gamma interferon-expressing cells following protective mucosal immunization with alphavirus replicon particles. J Virol (2005) 1.00
Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America. Clin Infect Dis (2005) 0.99
Health burden of pertussis in infants and children. Pediatr Infect Dis J (2005) 0.99
A cost effectiveness analysis of the preferred antidotes for acute paracetamol poisoning patients in Sri Lanka. BMC Clin Pharmacol (2012) 0.99
The development of a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles. Vaccine (2005) 0.98
Incidence of persistent renal dysfunction in human immunodeficiency virus-infected children: associations with the use of antiretrovirals, and other nephrotoxic medications and risk factors. Pediatr Infect Dis J (2009) 0.96
Multidrug resistance in epilepsy and polymorphisms in the voltage-gated sodium channel genes SCN1A, SCN2A, and SCN3A: correlation among phenotype, genotype, and mRNA expression. Pharmacogenet Genomics (2008) 0.95
Aseptic meningitis: case definition and guidelines for collection, analysis and presentation of immunization safety data. Vaccine (2007) 0.94
Determination of serum antibody to Bordetella pertussis adenylate cyclase toxin in vaccinated and unvaccinated children and in children and adults with pertussis. Clin Infect Dis (2004) 0.94
Safety review of the purified chick embryo cell rabies vaccine: Data from the Vaccine Adverse Event Reporting System (VAERS), 1997-2005. Vaccine (2007) 0.94
Acupuncture for epilepsy. Cochrane Database Syst Rev (2008) 0.94
Guidelines for collection, analysis and presentation of vaccine safety data in pre- and post-licensure clinical studies. Vaccine (2008) 0.94
Active middle ear implants in patients undergoing subtotal petrosectomy: long-term follow-up. Otol Neurotol (2014) 0.94
Phase I safety and immunogenicity study of a candidate meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles. Clin Vaccine Immunol (2009) 0.93
Immunization-safety monitoring systems for the 2009 H1N1 monovalent influenza vaccination program. Pediatrics (2011) 0.93
Comparison of clinical characteristics of influenza and respiratory syncytial virus infection in hospitalised children and adolescents. Eur J Pediatr (2004) 0.93
Antibody response patterns to Bordetella pertussis antigens in vaccinated (primed) and unvaccinated (unprimed) young children with pertussis. Clin Vaccine Immunol (2010) 0.93
Seroprevalence and immunization history of selected vaccine preventable diseases in medical students. Vaccine (2005) 0.93
Ear surgery in infants under one year of age: its risks and implications for cochlear implant surgery. Otol Neurotol (2008) 0.93
Transplacentally acquired immunoglobulin G antibodies against measles, mumps, rubella and varicella-zoster virus in preterm and full term newborns. Pediatr Infect Dis J (2004) 0.92
Acupuncture for autism spectrum disorders (ASD). Cochrane Database Syst Rev (2011) 0.92
Electro-acupuncture protects against hypoxic-ischemic brain-damaged immature rat via hydrogen sulfide as a possible mediator. Neurosci Lett (2010) 0.92
The potency of the adjuvant, CpG oligos, is enhanced by encapsulation in PLG microparticles. J Pharm Sci (2008) 0.92
Malignancy in perinatally human immunodeficiency virus-infected children in the United States. Pediatr Infect Dis J (2005) 0.92
Prospective pertussis surveillance in Switzerland, 1991-2006. Vaccine (2011) 0.91
Helicobacter pylori lipopolysaccharide promotes a Th1 type immune response in immunized mice. Vaccine (2006) 0.91
Comparative coverage of supplementary and universally recommended immunizations in children at 24 months of age. Pediatr Infect Dis J (2012) 0.91
The parental appraisal of the morbidity of diarrhea in infants and toddlers (PAMODI) survey. Clin Pediatr (Phila) (2008) 0.90
No temporal association between influenza outbreaks and invasive pneumococcal infections. Arch Dis Child (2007) 0.90
Antibody responses against HIV in rhesus macaques following combinations of mucosal and systemic immunizations with chimeric alphavirus-based replicon particles. AIDS Res Hum Retroviruses (2006) 0.90
Effects of a Th1- versus a Th2-biased immune response in protection against Helicobacter pylori challenge in mice. Microb Pathog (2007) 0.90
Long-term clinical effectiveness of an acellular pertussis component vaccine and a whole cell pertussis component vaccine. Eur J Pediatr (2002) 0.90
Early viral suppression improves neurocognitive outcomes in HIV-infected children. AIDS (2015) 0.89
Carrier incidence for spinal muscular atrophy in southern Chinese. J Neurol (2004) 0.89
A 4-year study on clinical characteristics of children hospitalized with rotavirus gastroenteritis. Eur J Pediatr (2009) 0.89
Dynamics of acute and memory mucosal and systemic immune responses against HIV-1 envelope following immunizations through single or combinations of mucosal and systemic routes. Vaccine (2007) 0.89
A comparison of anionic nanoparticles and microparticles as vaccine delivery systems. Hum Vaccin (2007) 0.89
Exon 3 polymorphisms of dopamine D4 receptor (DRD4) gene and attention deficit hyperactivity disorder in Chinese children. Am J Med Genet B Neuropsychiatr Genet (2006) 0.89
Acupuncture for insomnia. Cochrane Database Syst Rev (2012) 0.88
The development of standardized case definitions and guidelines for adverse events following immunization. Vaccine (2007) 0.88
Metaanalysis of vaccine effectiveness in varicella outbreaks. Vaccine (2007) 0.88
Prevalence of neuromuscular diseases in Chinese children: a study in southern China. J Child Neurol (2003) 0.88